Orally Dissolving Tablets (ODT) Excipient 2025 to Grow at 3.3 CAGR with 17130 million Market Size: Analysis and Forecasts 2033

Key Insights

The global Orally Dissolving Tablets (ODT) excipient market size was valued at USD 17,130 million in 2025 and is projected to reach USD 24,320 million by 2033, exhibiting a CAGR of 3.3% during the forecast period. ODTs provide rapid and convenient drug delivery, making them increasingly popular for various applications, including drug administration to geriatric and pediatric patients. The growing prevalence of chronic diseases, such as cardiovascular diseases, neurological disorders, and diabetes, is driving the demand for ODTs, as they offer enhanced patient compliance and improved bioavailability.

The market for ODT excipients is segmented based on type and application. Key types of excipients include binders, glidents, diluents, disintegrants, sweeteners, and others. Binders are the most significant segment, contributing a large share to the market. The application segment includes anti-psychotics drugs, anti-epileptics drugs, and others. Key players in the ODT excipient market include BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, and Fuji Chemical Industries.

Orally Dissolving Tablets (ODT) Excipient Trends

The global orally dissolving tablets (ODT) excipient market is projected to reach USD 1,500 million by 2027, growing at a CAGR of 6.5% during the forecast period. The increasing prevalence of chronic diseases, the growing geriatric population, and the rising demand for patient-centric drug delivery systems are driving the growth of the market.

Key market insights include:

• The binders segment is expected to dominate the market, accounting for over 40% of the global revenue share in 2027.
• The anti-psychotics drug application segment is anticipated to grow at the highest CAGR of 7.5% during the forecast period.
• The Asia Pacific region is expected to witness the fastest growth, with a CAGR of 8.0%, during the forecast period.

Driving Forces: What's Propelling the Orally Dissolving Tablets (ODT) Excipient

The growth of the ODT excipient market is attributed to several driving forces, including:

• The increasing prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and cancer, which require long-term medication.
• The growing geriatric population, which faces difficulty in swallowing traditional tablets and capsules.
• The rising demand for patient-centric drug delivery systems, which offer improved patient compliance and convenience.
• The advancements in ODT technology, leading to the development of fast-dissolving and taste-masked excipients.

Challenges and Restraints in Orally Dissolving Tablets (ODT) Excipient

Despite the growth potential, the ODT excipient market faces certain challenges and restraints, including:

• The high cost of ODT excipients compared to traditional excipients.
• The technical complexities involved in the formulation and manufacturing of ODTs.
• The stability concerns associated with ODTs, which can affect their shelf life.
• The limited availability of ODT-compatible excipients for certain active pharmaceutical ingredients (APIs).

Key Region or Country & Segment to Dominate the Market

The Asia Pacific region is expected to dominate the ODT excipient market, with a significant share of over 45% in 2027. The region is driven by the growing population, the increasing prevalence of chronic diseases, and the rising demand for patient-centric drug delivery systems.

Within the Asia Pacific region, China is anticipated to be the largest market for ODT excipients, followed by India and Japan.

The binders segment is expected to dominate the global ODT excipient market throughout the forecast period. Binders play a crucial role in providing structural integrity and mechanical strength to ODTs, ensuring their stability and disintegration properties.

Growth Catalysts in Orally Dissolving Tablets (ODT) Excipient Industry

Several factors are expected to act as growth catalysts for the ODT excipient industry, including:

• The growing demand for ODTs in pediatric and geriatric populations.
• The increasing use of ODTs in clinical trials for rapid drug delivery.
• The advancements in ODT technology, such as the development of fast-dissolving and taste-masked excipients.
• The growing awareness of the benefits of ODTs among healthcare professionals and patients.

Leading Players in the Orally Dissolving Tablets (ODT) Excipient

The key players in the global ODT excipient market include:

• BASF
• JRS Pharma
• Roquette
• ABF Ingredients
• DFE Pharma
• Evonik
• Merck KGaA
• Ashland
• Meggle Pharma
• Shin-Etsu
• Fuji Chemical Industries
• McePharma (Vivesa holding)
• Cargill Incorporated
• Daicel Corporation
• Anhui Sunhere Pharmaceutical

Significant Developments in Orally Dissolving Tablets (ODT) Excipient Sector

Some of the significant developments in the ODT excipient sector include:

• BASF launched a new line of ODT excipients called Soluplus®, which offers improved solubility and bioavailability.
• JRS Pharma introduced a new generation of ODT excipients called PROSOLV® SMCC, which provides fast disintegration and taste-masking properties.
• Roquette developed a new ODT excipient called Pharmaburst®, which offers high drug loading capacity and rapid disintegration.

Comprehensive Coverage Orally Dissolving Tablets (ODT) Excipient Report

The comprehensive Orally Dissolving Tablets (ODT) Excipient report provides a detailed analysis of the market, including:

• Market size and growth projections
• Key market trends and drivers
• Challenges and restraints
• Competitive landscape
• Leading players and their strategies
• Significant industry developments

Orally Dissolving Tablets (ODT) Excipient Segmentation

• 1. Type
  • 1.1. Overview: Global Orally Dissolving Tablets (ODT) Excipient Consumption Value
  • 1.2. Binders
  • 1.3. Glidents
  • 1.4. Diluents
  • 1.5. Disintegrants
  • 1.6. Sweeteners
  • 1.7. Others
• 2. Application
  • 2.1. Overview: Global Orally Dissolving Tablets (ODT) Excipient Consumption Value
  • 2.2. Anti-Psychotics Drug
  • 2.3. Anti-Epileptics Drug
  • 2.4. Others

Orally Dissolving Tablets (ODT) Excipient Segmentation By Geography

• 1. North America
  • 1.1. United States
  • 1.2. Canada
  • 1.3. Mexico
• 2. South America
  • 2.1. Brazil
  • 2.2. Argentina
  • 2.3. Rest of South America
• 3. Europe
  • 3.1. United Kingdom
  • 3.2. Germany
  • 3.3. France
  • 3.4. Italy
  • 3.5. Spain
  • 3.6. Russia
  • 3.7. Benelux
  • 3.8. Nordics
  • 3.9. Rest of Europe
• 4. Middle East & Africa
  • 4.1. Turkey
  • 4.2. Israel
  • 4.3. GCC
  • 4.4. North Africa
  • 4.5. South Africa
  • 4.6. Rest of Middle East & Africa
• 5. Asia Pacific
  • 5.1. China
  • 5.2. India
  • 5.3. Japan
  • 5.4. South Korea
  • 5.5. ASEAN
  • 5.6. Oceania
  • 5.7. Rest of Asia Pacific